I agree that this site is using cookies. You can find further informations here.
X
Cingolani, Linda
19  results:
Search for persons X
?
1

Switching from Infliximab Originator to SB2 Biosimilar in I..:

Massimi, Davide ; Barberio, Brigida ; Bertani, Lorenzo...
Therapeutic Advances in Gastroenterology.  14 (2021)  - p. 175628482110233 , 2021
Link: https://doi.org/10.1177/..
 
?
2

A propensity score-weighted comparison between adalimumab o..:

Barberio, Brigida ; Cingolani, Linda ; Canova, Cristina...
Therapeutic Advances in Gastroenterology.  14 (2021)  - p. 175628482110314 , 2021
Link: https://doi.org/10.1177/..
 
?
3

Adalimumab biosimilars, ABP501 and SB5, are equally effecti..:

Cingolani, Linda ; Barberio, Brigida ; Zingone, Fabiana...
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
4

A Survey on Nutritional Knowledge in Coeliac Disease Compar..:

Marsilio, Ilaria ; Savarino, Edoardo Vincenzo ; Barberio, Brigida...
Nutrients.  12 (2020)  4 - p. 1110 , 2020
Link: https://doi.org/10.3390/..
 
?
5

A propensity score-weighted comparison between adalimumab o..:

Barberio, Brigida ; Cingolani, Linda ; Canova, Cristina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295962/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
6

A propensity score-weighted comparison between adalimumab o..:

Barberio, Brigida ; Cingolani, Linda ; Canova, Cristina...
info:eu-repo/semantics/altIdentifier/pmid/34349836.  , 2021
Link: https://hdl.handle.net/1..
 
?
7

Adalimumab biosimilars, ABP501 and SB5, are equally effecti..:

Cingolani, Linda ; Barberio, Brigida ; Zingone, Fabiana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121777/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Switching from Infliximab Originator to SB2 Biosimilar in I..:

Massimi, Davide ; Barberio, Brigida ; Bertani, Lorenzo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239954/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

A Survey on Nutritional Knowledge in Coeliac Disease Compar..:

Marsilio, Ilaria ; Savarino, Edoardo Vincenzo ; Barberio, Brigida...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230195/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
10

Perception of the COVID-19 Pandemic Among Patients With Inf..:

Zingone, Fabiana ; Siniscalchi, Monica ; Savarino, Edoardo Vincenzo...
https://www.jmir.org/2020/11/e19574.  , 2020
Link: https://doi.org/10.2196/..
 
?
11

Switching from Infliximab Originator to SB2 Biosimilar in I..:

Davide Massimi ; Brigida Barberio ; Lorenzo Bertani...
https://doi.org/10.1177/17562848211023384.  , 2021
Link: https://doi.org/10.1177/..
 
?
12

A propensity score-weighted comparison between adalimumab o..:

Brigida Barberio ; Linda Cingolani ; Cristina Canova...
https://doi.org/10.1177/17562848211031420.  , 2021
Link: https://doi.org/10.1177/..
 
?
13

Adalimumab biosimilars, ABP501 and SB5, are equally effecti..:

Linda Cingolani ; Brigida Barberio ; Fabiana Zingone...
https://doi.org/10.1038/s41598-021-89790-4.  , 2021
Link: https://doi.org/10.1038/..
 
?
14

A Survey on Nutritional Knowledge in Coeliac Disease Compar..:

Ilaria Marsilio ; Edoardo Vincenzo Savarino ; Brigida Barberio...
https://www.mdpi.com/2072-6643/12/4/1110.  , 2020
Link: https://doi.org/10.3390/..
 
?
15

A Survey on Nutritional Knowledge in Coeliac Disease Compar..:

Ilaria Marsilio ; Edoardo Vincenzo Savarino ; Brigida Barberio...
Nutritional Epidemiology.  , 2020
Link: https://doi.org/10.3390/..
 
1-15